{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:21:17Z","timestamp":1772781677926,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1016\/s1359-6446(01)01794-9","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T00:42:39Z","timestamp":1027644159000},"page":"628-636","source":"Crossref","is-referenced-by-count":25,"title":["Transgenic knockouts as part of high-throughput, evidence-based target selection and validation strategies"],"prefix":"10.1016","volume":"6","author":[{"given":"Stephen","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1359-6446(01)01794-9_BIB1","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/nbt1196-1516","article-title":"Genomic sciences and the medicines of tomorrow","volume":"14","author":"Drews","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1359-6446(97)01162-8","article-title":"Obtaining value from the human genome: a challenge for the pharmaceutical industry","volume":"3","author":"Spence","year":"1998","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1359-6446(99)01308-2","article-title":"Genomics: the race is on","volume":"4","author":"Spence","year":"1999","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1359-6446(99)01310-0","article-title":"Functional genomics: from genes to new therapies","volume":"4","author":"Dyer","year":"1999","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/14622416.1.4.433","article-title":"Transgenic gene knock-outs: functional genomics and therapeutic target selection","volume":"1","author":"Harris","year":"2000","journal-title":"Pharmacogenomics"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB6","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug discovery: a historical perspective","volume":"287","author":"Drews","year":"2000","journal-title":"Science"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/75949","article-title":"How to count\u2026human genes","volume":"25","author":"Aparicio","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1359-6446(01)01724-X","article-title":"Impact of the human genome sequence for in silico target discovery","volume":"6","author":"Sanseau","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1359-6446(99)01311-2","article-title":"Genomics and intellectual property rights","volume":"4","author":"Thomas","year":"1999","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(00)00005-2","article-title":"Biomedical discovery with DNA arrays","volume":"102","author":"Young","year":"2000","journal-title":"Cell"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB12","series-title":"Proteomics: A Trends Guide","first-page":"7","article-title":"Experimentalism in Proteomics","author":"Thomas","year":"2000"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S1359-6446(99)01392-6","article-title":"Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination","volume":"4","author":"Taylor","year":"1999","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB14","first-page":"11","article-title":"OMIM passes the 1000-disease-gene mark","volume":"25","author":"Antonarakis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.11.1.1","article-title":"Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice","volume":"11","author":"Bedell","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1101\/gad.11.1.11","article-title":"Mouse models of human disease. Part II: recent progress and future directions","volume":"11","author":"Bedell","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/mutage\/14.1.141","article-title":"Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens","volume":"14","author":"Dean","year":"1999","journal-title":"Mutagenesis"},{"key":"10.1016\/S1359-6446(01)01794-9_BIB18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0378-4274(99)00227-1","article-title":"Current status and use of short\/medium term models for carcinogenicity testing of pharmaceuticals \u2013 scientific perspective","volume":"112","author":"Storer","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-6147(98)01279-6","article-title":"Opioids: first lessons from knockout mice","volume":"20","author":"Kieffer","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB20","first-page":"1","article-title":"In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors","volume":"293","author":"Kable","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-6147(99)01305-X","article-title":"Insight into adenosine receptor function using antisense and gene-knockout approaches","volume":"20","author":"Nyce","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0165-6147(99)01325-5","article-title":"Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission","volume":"20","author":"Murphy","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/82825","article-title":"Choose your target","volume":"26","author":"Capecchi","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/S1359-6446(01)01794-9_BIB24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/33423","article-title":"Disruption and sequence identification of 2000 genes in mouse embryonic stem cells","volume":"392","author":"Zambrowicz","year":"1998","journal-title":"Nature"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644601017949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644601017949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T15:29:20Z","timestamp":1555428560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644601017949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1359644601017949"],"URL":"https:\/\/doi.org\/10.1016\/s1359-6446(01)01794-9","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}